Patent Assignment
Reel/Frame 027028/0048
Change of Name
Recorded: 2011-10-06
Received: 2011-10-06
Pages: 4
Assignor
EURAND, INCORPORATED
Executed: 2011-07-12
Assignee
APTALIS PHARMATECH, INC.
845 CENTER DRIVE, VANDALIA, OH, 45377, UNITED STATES
Covered Properties
(24)
Rapid Dissolve Tablet Compositions for Vaginal Administration
Application:
61/481,582 →
Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting
Application:
12/956,249 →
Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
Application:
12/956,543 →
Orally Administered Corticosteroid Compositions
Application:
12/896,005 →
Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics
Application:
12/772,776 →
Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
Application:
12/772,770 →
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
Application:
12/688,493 →
Taste Masked Topiramate Composition and an Orally Disintegrating Tablet Comprising Such
Application:
61/293,455 →
Pharmaceutical Compositions Comprising Anti-Psychotic Drugs
Application:
61/293,067 →
Compositions Comprising Melperone
Application:
12/639,496 →
Compositions Comprising Melperone and Controlled-Release Dosage Forms
Application:
12/639,470 →
Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting
Application:
61/265,233 →
Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
Application:
61/265,213 →
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Application:
12/487,339 →
Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
Application:
61/174,780 →
Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics
Application:
61/174,788 →
Orally Disintegrating Tablets Comprising Diphenhydramine
Application:
12/331,963 →
Preparation of controlled release skeletal muscle relaxant dosage forms
Application:
12/314,290 →
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Application:
12/209,285 →
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Application:
61/074,464 →
Compositions Comprising Weakly Basic Drugs and Controlled-Release Dosage Forms
Application:
61/045,170 →
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Application:
61/035,840 →
Orally Disintegrating and Taste-Masked Compositions of Ranitidine and Methods of Manufacture
Application:
61/028,390 →
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Application:
60/992,815 →